Rhumbline Advisers Taro Pharmaceutical Industries LTD Transaction History

Rhumbline Advisers

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$0.0 - $42.97 $0 - $129,683	3,018 Added 31.41%	12,625 $0
Q1 2024 May 09, 2024	BUY	$40.97 - $43.33 $10,529 - $11,135	257 Added 2.75%	9,607 $406,000
Q4 2023 Feb 08, 2024	SELL	$32.77 - $42.31 $13,304 - $17,177	-406 Reduced 4.16%	9,350 $390,000
Q3 2023 Nov 09, 2023	BUY	$35.46 - $40.13 $14,857 - $16,814	419 Added 4.49%	9,756 $367,000
Q2 2023 Aug 08, 2023	BUY	$24.24 - $40.97 $226,328 - $382,536	9,337 New	9,337 $354,000

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.